Tom Strange

Tom is a Director and joined the team in 2023.
Tom has over 15 years of professional experience across a variety of clinical and operational roles.
Prior to joining iCON, Tom was Director of Corporate Strategy at MiroBio.
Tom has previously worked at McKinsey & Co and was an Associate Professor of Medicine at UCL.
Tom is primarily focused on overseeing investments across iCON’s funds.
Tom holds a Master’s degree in Bioscience Enterprise (Cambridge University), as well as a Medical Degree & Bachelor’s in Medical Science (Nottingham University).
He is also a Fellow of the Royal College of Radiologists and a Member of the Royal College of Surgeons of England.